1. Home
  2. Labeler Index
  3. Aizant Drug Research Solutions Pvt Ltd
  4. NDC Product Code: 69025-101 Tenofovir Disoproxil Fumarate

NDC 69025-101 Tenofovir Disoproxil Fumarate

View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. Product Characteristics
  4. What is NDC 69025-101?
  5. Tenofovir Disoproxil Fumarate Uses
  6. Active Ingredients UNII Codes
  7. NDC to RxNorm Crosswalk

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
69025-101
Proprietary Name:
Tenofovir Disoproxil Fumarate
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
Aizant Drug Research Solutions Pvt Ltd
Labeler Code:
69025
Product Label ID:
79b774fe-abcd-47b4-943b-e82fc87bd6df
Start Marketing Date: [9]
01-26-2018
Listing Expiration Date: [11]
12-31-2017
Exclude Flag: [12]
I
Code Structure:
Code Navigator:

Product Characteristics

Color(s):
WHITE (C48325)
Shape:
TRIANGLE (C48353)
ROUND (C48348)
Size(s):
10 MM
11 MM
Imprint(s):
100;A
101;A
Score:
1

Product Packages

NDC Code 69025-101-01

Package Description: 30 TABLET, FILM COATED in 1 BOTTLE

Product Details

What is NDC 69025-101?

The NDC code 69025-101 is assigned by the FDA to the product Tenofovir Disoproxil Fumarate which is product labeled by Aizant Drug Research Solutions Pvt Ltd. The product's dosage form is . The product is distributed in a single package with assigned NDC code 69025-101-01 30 tablet, film coated in 1 bottle . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Tenofovir Disoproxil Fumarate?

Tenofovir is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Tenofovir belongs to a class of drugs known as nucleotide reverse transcriptase inhibitors (NRTIs). Tenofovir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, do all of the following: (1) continue to take all HIV medications exactly as prescribed by your doctor, (2) always use an effective barrier method (latex or polyurethane condoms/dental dams) during all sexual activity, and (3) do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. Tenofovir is also used to treat a certain type of liver infection called chronic hepatitis B infection. It helps to decrease the amount of hepatitis B virus in your body by interfering with virus growth.

Which are Tenofovir Disoproxil Fumarate UNII Codes?

The UNII codes for the active ingredients in this product are:

  • TENOFOVIR DISOPROXIL FUMARATE (UNII: OTT9J7900I)
  • TENOFOVIR ANHYDROUS (UNII: W4HFE001U5) (Active Moiety)

What is the NDC to RxNorm Crosswalk for Tenofovir Disoproxil Fumarate?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".